Education
About Us
Working with TipRanks
Follow Us
Therapeutic Solutions International (TSOI)
:TSOI
Total Valuation
Therapeutic Solutions International has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Therapeutic Solutions International has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Therapeutic Solutions International’s return on equity (ROE) is -1.93 and return on invested capital (ROIC) is -91.64%.
Return on Equity (ROE)-1.93
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-91.64%
Return on Capital Employed (ROCE)-1.43
Revenue Per Employee33.00K
Profits Per Employee-723.27K
Employee Count3
Asset Turnover0.03
Inventory Turnover1.63
Valuation Ratios
The current PE Ratio of Therapeutic Solutions International is ―. Therapeutic Solutions International’s PEG ratio is 0.03.
PE Ratio―
PS Ratio32.01
PB Ratio2.82
Price to Fair Value2.82
Price to FCF-2.96
Price to Operating Cash Flow-1.77
PEG Ratio0.03
Income Statement
In the last 12 months, Therapeutic Solutions International had revenue of 98.99K and earned -2.17M in profits. Earnings per share was 0.00.
Revenue98.99K
Gross Profit62.23K
Operating Income-1.99M
Pretax Income-2.22M
Net Income-2.17M
EBITDA-1.49M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -484.11K and capital expenditures -16.14M, giving a free cash flow of -16.63M billion.
Operating Cash Flow-484.11K
Free Cash Flow-16.63M
Free Cash Flow per Share-10.00T>
Dividends & Yields
Therapeutic Solutions International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Therapeutic Solutions International upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Therapeutic Solutions International as a current ratio of 0.05, with Debt / Equity ratio of 73.84%
Current Ratio0.05
Quick Ratio0.03
Debt to Market Cap0.24
Net Debt to EBITDA-0.58
Interest Coverage Ratio-4.69
Taxes
In the past 12 months, Therapeutic Solutions International has paid 2.25K in taxes.
Income Tax2.25K
Effective Tax Rate>-0.01
Enterprise Valuation
Therapeutic Solutions International EV to EBITDA ratio is -2.71, with an EV/FCF ratio of -3.76.
EV to Sales40.70
EV to EBITDA-2.71
EV to Free Cash Flow-3.76
EV to Operating Cash Flow-3.82
Balance Sheet
Therapeutic Solutions International has $9.23K in cash and marketable securities with $929.63K in debt, giving a net cash position of -$920.39K billion.
Cash & Marketable Securities$9.23K
Total Debt$929.63K
Net Cash-$920.39K
Net Cash Per Share-$10.00T>
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 81.93%, with operating margin of -2006.67%, and net profit margin of -2191.86%.
Gross Margin81.93%
Operating Margin-2006.67%
Pretax Margin-2245.04%
Net Profit Margin-2191.86%
EBITDA Margin-1502.53%
EBIT Margin-1817.47%
Analyst Forecast
The average price target for Therapeutic Solutions International is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―